Clinical trial

SABR for T1-2a N1 NSCLC

NCT03321760

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-01-01

PhasePHASE2

Study timeline

Study start (estimated)2022-01-01Date precision: day

Registry last updated2022-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Stereotactic Ablative Radiation Therapy (SABR)RADIATION

Sponsors & collaborators

Indiana Universitylead sponsor

Mapped research locations

IndianapolisIndiana, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03321760 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.